Trial intelligence / Profile preview

FF/GW642444M in mild asthma

NCT01128595Phase 2Completed

Sponsor
GSK
Start
May 2010
Primary completion
May 2011
Modality
Orthosteric Ligands
Countries
3
01

Overview

A Phase 2 trial of fluticasone, vilanterol in asthma, sponsored by GSK. Started May 2010; status: completed.

02

Drugs

fluticasonevilanterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01128595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01128595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call